Idasanutlin: Clinical Trials

1 trial of Idasanutlin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Idasanutlin: new trials by email Literature Review of Idasanutlin trials Research Report on Idasanutlin

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Cytarabine, Idasanutlin, Placebo - Leukemia, Myeloid, Acute
Phase 3TerminatedHoffmann-La Roche4472015-12-302022-01-11

Conditions studied

Leukemia, Myeloid, Acute (1)

Sponsors

Hoffmann-La Roche (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Panama (1)  ·  Russia (1)  ·  South Korea (1)

Results publications

PMID 32167393

NIH funding

2014 (1)